|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
|
US4265814A
(en)
|
1978-03-24 |
1981-05-05 |
Takeda Chemical Industries |
Matansinol 3-n-hexadecanoate
|
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164687A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS5566585A
(en)
|
1978-11-14 |
1980-05-20 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
|
JPS55164685A
(en)
|
1979-06-08 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164686A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4309428A
(en)
|
1979-07-30 |
1982-01-05 |
Takeda Chemical Industries, Ltd. |
Maytansinoids
|
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
RU2188819C2
(ru)
|
1996-08-12 |
2002-09-10 |
Селджин Корпорейшн |
НОВЫЕ ИММУНОТЕРАПЕВТИЧЕСКИЕ СОЕДИНЕНИЯ, СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ СНИЖЕНИЯ УРОВНЕЙ ФДЭ, TNFα И NFκB
|
|
US5969516A
(en)
|
1997-07-25 |
1999-10-19 |
Ntc, Inc. |
Electrical circuit interrupter device locator
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
CA2453528C
(en)
|
2001-08-01 |
2011-07-26 |
Cellomics, Inc. |
Novel fusion proteins and assays for molecular binding
|
|
US6660510B2
(en)
|
2001-12-17 |
2003-12-09 |
Food Industry Research And Development |
Transglutaminase gene of Streptoverticillium ladakanum and the transglutaminase encoded therefrom
|
|
US7435797B2
(en)
|
2002-04-10 |
2008-10-14 |
Genentech, Inc. |
Anti-HER2 antibody variants
|
|
JP2006507322A
(ja)
|
2002-11-14 |
2006-03-02 |
シンタルガ・ビーブイ |
多重自己脱離放出スペーサーとして構築されたプロドラッグ
|
|
ES2661213T3
(es)
|
2003-01-17 |
2018-03-28 |
Dupont Nutrition Biosciences Aps |
Método para la producción in situ de un emulsionante en un producto alimenticio
|
|
US7955814B2
(en)
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
AU2008215422B2
(en)
|
2007-02-15 |
2011-07-14 |
Ajinomoto Co., Inc. |
Transglutaminase having disulfide bond introduced therein
|
|
KR20090123857A
(ko)
|
2007-02-22 |
2009-12-02 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
특이성이 개선된 트랜스글루타미나아제 변이체
|
|
DK2474557T3
(da)
|
2007-07-16 |
2014-11-10 |
Genentech Inc |
Anti-CD79b-antistoffer og immunkonjugater og fremgangsmåder til anvendelse
|
|
CA2701071C
(en)
|
2007-09-26 |
2018-03-27 |
Gemin X Pharmaceuticals Canada Inc. |
Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
|
|
SG187517A1
(en)
|
2008-01-31 |
2013-02-28 |
Genentech Inc |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
|
JP2012523383A
(ja)
|
2009-04-08 |
2012-10-04 |
ファウルシュティヒ，ハインツ |
がんの治療のためのアマトキシンと複合体形成した標的結合部分
|
|
US9233173B2
(en)
|
2009-04-08 |
2016-01-12 |
Deutsches Krebsforschungszentrum |
Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
|
|
US9066991B2
(en)
|
2009-12-22 |
2015-06-30 |
Lifebond Ltd. |
Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
|
|
EP4012714A1
(en)
|
2010-03-23 |
2022-06-15 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
WO2013040142A2
(en)
|
2011-09-16 |
2013-03-21 |
Iogenetics, Llc |
Bioinformatic processes for determination of peptide binding
|
|
CN106243023A
(zh)
|
2010-09-03 |
2016-12-21 |
福马Tm有限责任公司 |
用于抑制nampt的胍化合物和组合物
|
|
EP3409287B9
(en)
|
2010-09-29 |
2021-07-21 |
Agensys, Inc. |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
|
ES2402254T3
(es)
|
2010-09-30 |
2013-04-30 |
Heidelberg Pharma Ag |
Conjugados de amatoxinas con ligadores mejorados
|
|
US9676871B2
(en)
|
2010-11-05 |
2017-06-13 |
Pfizer Inc. |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
EP2497499A1
(en)
|
2011-03-10 |
2012-09-12 |
Heidelberg Pharma GmbH |
Amatoxin-conjugates with improved linkages
|
|
WO2013049830A2
(en)
|
2011-09-30 |
2013-04-04 |
The Washington University |
Tip-1 and grp-78 binding peptides and method of identifying peptide receptors
|
|
US9764038B2
(en)
|
2011-12-23 |
2017-09-19 |
Innate Pharma |
Enzymatic conjugation of antibodies
|
|
WO2014009426A2
(en)
|
2012-07-13 |
2014-01-16 |
Innate Pharma |
Screening of conjugated antibodies
|
|
EP2774624A1
(en)
|
2013-03-04 |
2014-09-10 |
Heidelberg Pharma GmbH |
Amatoxin derivatives
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
EP2968582B1
(en)
|
2013-03-15 |
2020-07-01 |
Innate Pharma |
Solid phase tgase-mediated conjugation of antibodies
|
|
JP6744212B2
(ja)
|
2013-06-21 |
2020-08-19 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
ポリペプチドの酵素的結合
|
|
EP3027224B1
(en)
|
2013-07-31 |
2020-06-03 |
Rinat Neuroscience Corp. |
Engineered polypeptide conjugates using transglutaminase
|
|
CA2921532A1
(en)
|
2013-10-09 |
2015-04-16 |
Eli Lilly And Company |
Novel pyridyloxyacetyl tetrahydroisoquinoline compounds useful as nampt inhibitors
|
|
JP6865584B2
(ja)
|
2013-12-23 |
2021-04-28 |
コヴァラブ |
化合物の共有結合性コンジュゲーションのためのｍＴＧ基質
|
|
SI3134127T1
(sl)
|
2014-04-25 |
2020-06-30 |
Rinat Neuroscience Corp. |
Konjugati zdravil s protitelesi z visoko stopnjo zdravila
|
|
KR102451080B1
(ko)
|
2014-06-12 |
2022-10-06 |
씨에스피씨 메가리스 바이오파마슈티칼 씨오., 엘티디. |
효소적 방법을 통한 균일한 항체 약물 접합체
|
|
ES2797754T3
(es)
|
2014-08-28 |
2020-12-03 |
Pfizer |
Enlazadores moduladores de la estabilidad para su uso con conjugados de fármaco y anticuerpo
|
|
ES2871624T3
(es)
|
2014-12-19 |
2021-10-29 |
Hoffmann La Roche |
Transglutaminasas microbianas, sustratos para las mismas y procedimientos para el uso de las mismas
|
|
WO2016128410A1
(en)
|
2015-02-09 |
2016-08-18 |
Nbe Therapeutics Ag |
Maytansine-drug conjugates of her- 2 specific binding proteins generated by site specific sortase-enzyme mediated conjugation
|
|
CN107406496A
(zh)
|
2015-03-10 |
2017-11-28 |
百时美施贵宝公司 |
可通过转谷氨酰胺酶缀合的抗体和由其制备的缀合物
|
|
EP3069734A1
(en)
|
2015-03-17 |
2016-09-21 |
Exiris S.r.l. |
Cryptophycin-based antibody-drug conjugates with novel self-immolative linkers
|
|
RU2018102358A
(ru)
|
2015-06-23 |
2019-07-25 |
Байер Фарма Акциенгезельшафт |
Нацеленные конъюгаты ksp ингибиторов
|
|
CA2994741A1
(en)
|
2015-08-07 |
2017-02-16 |
Merck Patent Gmbh |
A transglutamine tag for efficient site-specific bioconjugation
|
|
US10689458B2
(en)
|
2015-11-30 |
2020-06-23 |
Pfizer Inc. |
Site specific HER2 antibody drug conjugates
|
|
US11135304B2
(en)
|
2015-12-18 |
2021-10-05 |
Eisai R&D Management Co., Ltd. |
C-terminal lysine conjugated immunoglobulins
|
|
EP3272864A1
(en)
|
2016-07-20 |
2018-01-24 |
Paul Scherrer Institut |
Solid-phase immobilization of microbial transglutaminase mtg on microbeads for protein conjugation
|
|
CN118307682A
(zh)
|
2016-09-27 |
2024-07-09 |
埃皮辛特瑞柯斯公司 |
免疫调节性融合蛋白
|
|
EP3665193A1
(en)
|
2017-08-07 |
2020-06-17 |
NBE Therapeutics AG |
Anthracycline-based antibody drug conjugates having high in vivo tolerability
|
|
WO2019057772A1
(en)
*
|
2017-09-19 |
2019-03-28 |
Paul Scherrer Institut |
METHOD FOR CONJUGATING TRANSGLUTAMINASE AND BINDING SEQUENCE
|
|
JP7324749B2
(ja)
|
2017-10-27 |
2023-08-10 |
ファイザー・インク |
Ｃｄ１２３に特異的な抗体および抗体－薬物コンジュゲートならびにその使用
|
|
JP7629902B2
(ja)
*
|
2019-03-19 |
2025-02-14 |
パウル・シェラー・インスティトゥート |
グリシンベースリンカーを用いたトランスグルタミナーゼコンジュゲーション法
|
|
KR20230069211A
(ko)
|
2020-09-18 |
2023-05-18 |
아라리스 바이오테크 아게 |
아미노산-기반 링커를 사용한 트란스글루타미나제 접합 방법
|